Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.
Clinical Motion Analysis Laboratory, University Hospitals Leuven, Pellenberg, Belgium.
Dev Med Child Neurol. 2019 Jul;61(7):783-790. doi: 10.1111/dmcn.14056. Epub 2018 Oct 15.
This cross-sectional investigation evaluated whether recurrent botulinum neurotoxin A (BoNT-A) interventions to the medial gastrocnemius have an influence on muscle morphology, beyond Gross Motor Function Classification System (GMFCS) level.
A cohort of typically developing children (n=67; 43 males, 24 females; median age 9y 11mo [range 7y 10mo-11y 6mo]), a cohort of children with spastic cerebral palsy (CP) naive to BoNT-A interventions (No-BoNT-A; n=19; 10 males, nine females; median age 9y 3mo [range 8y 5mo-10y 10mo]) and a cohort of children with spastic CP with a minimum of three recurrent BoNT-A interventions to the medial gastrocnemius (BoNT-A; n=19; 13 males, six females; median age 9y 8mo [range 7y 3mo-10y 7mo]) were recruited. Three-dimensional freehand ultrasound was used to estimate medial gastrocnemius volume normalized to body mass and echo-intensity.
Normalized medial gastrocnemius volume and echo-intensity significantly differed between the two spastic CP cohorts (p≤0.05), with the BoNT-A cohort having larger alterations. Associations between normalized medial gastrocnemius volume and echo-intensity were highest in the No-BoNT-A cohort, followed by the BoNT-A cohort. Multiple regression analyses revealed that both GMFCS level and BoNT-A intervention history were significantly associated with smaller normalized medial gastrocnemius volume and higher echo-intensity.
Recurrent BoNT-A interventions may induce alterations to medial gastrocnemius volume and echo-intensity beyond the natural history of the spastic CP pathology.
In spastic cerebral palsy, medial gastrocnemius volumes are smaller and echo-intensities higher compared with typical development. Alterations after botulinum neurotoxin A intervention (BoNT-A) are larger than in no BoNT-A intervention. Gross Motor Function Classification System level and BoNT-A history significantly associate with medial gastrocnemius and echo-intensity alterations.
本横断面研究评估了反复使用肉毒毒素 A(BoNT-A)治疗内侧腓肠肌是否会对肌肉形态产生影响,而不仅仅是基于粗大运动功能分类系统(GMFCS)水平。
本研究纳入了一组典型发育儿童(n=67;43 名男性,24 名女性;中位年龄 9 岁 11 个月[范围 7 岁 10 个月-11 岁 6 个月])、一组未接受 BoNT-A 干预的痉挛性脑瘫儿童(No-BoNT-A;n=19;10 名男性,9 名女性;中位年龄 9 岁 3 个月[范围 8 岁 5 个月-10 岁 10 个月])和一组接受至少三次内侧腓肠肌 BoNT-A 重复治疗的痉挛性脑瘫儿童(BoNT-A;n=19;13 名男性,6 名女性;中位年龄 9 岁 8 个月[范围 7 岁 3 个月-10 岁 7 个月])。使用自由手三维超声估计内侧腓肠肌体积与体重的比值和回声强度。
两个痉挛性脑瘫组的内侧腓肠肌体积和回声强度均有显著差异(p≤0.05),BoNT-A 组的变化更大。No-BoNT-A 组中,正常化内侧腓肠肌体积与回声强度之间的相关性最高,其次是 BoNT-A 组。多元回归分析显示,GMFCS 水平和 BoNT-A 干预史均与正常化内侧腓肠肌体积减小和回声强度增加显著相关。
在痉挛性脑瘫中,内侧腓肠肌的体积和回声强度与脑瘫病理的自然史相比发生了变化。反复使用 BoNT-A 治疗可能会导致这种变化。
与典型发育相比,痉挛性脑瘫患者的内侧腓肠肌体积较小,回声强度较高。BoNT-A 干预后的变化大于无 BoNT-A 干预。GMFCS 水平和 BoNT-A 治疗史与内侧腓肠肌和回声强度的变化显著相关。